Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Luiz R.R. Castello-Branco"'
Autor:
Luiz R.R. Castello-Branco, Milton Ozório Moraes, Carlos G.G. Ponte, Paulo R. Z. Antas, Mariana A. Hacker, Floriano P. Silva
Publikováno v:
Human Vaccines & Immunotherapeutics. 14:28-35
Tuberculosis (TB) remains among the world's leading cause of mortality. For its control, studies of TB vaccines are needed. Since live-attenuated Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the only TB vaccine currently in use, studies on
Autor:
Thaíze Pedro, Fernanda C. Silva, Luiz R.R. Castello-Branco, Matheus Rogério de Almeida, Lawrence Henrique Paz Albuquerque, Periela da Silva Sousa-Vasconcelos, Carlos G.G. Ponte, Natália Lins da Silva Gomes, Otacilio C. Moreira, R.T. Pinho, Paulo R. Z. Antas
Publikováno v:
Journal of Inflammation, Vol 16, Iss 1, Pp 1-9 (2019)
Background Caused by Mycobacterium tuberculosis, tuberculosis (TB) is an extremely contagious disease predominantly affecting the lungs. TB is found worldwide and has a major impact on public health safety primarily due to its high mortality rate. Ap
Autor:
Luiz R.R. Castello-Branco, Paulo R. Z. Antas, Jessica R. Lima, Mariana Siqueira, Carlos G.G. Ponte, Leandro Peres, Suelen Marinho, Thaíze Pedro
Publikováno v:
Journal of Inflammation (London, England)
Background Tuberculosis (TB) is the second greatest killer worldwide that is caused by a single infectious agent. For its control, studies of TB vaccines are needed. Since Bacillus Calmette-Guerin (BCG) is the only vaccine against TB currently in use
Autor:
Edgar Badell, Nathalie Winter, Brigitte Gicquel, Luiz R.R. Castello-Branco, Simon O. Clark, Fabienne Nicolle, Laleh Majlessi, Frédéric Boudou, Philip Marsh, David Lewis, Claude Leclerc, Angelo Martino
Publikováno v:
Vaccine
Vaccine, Elsevier, 2009, 27 (1), pp.28-37. ⟨10.1016/j.vaccine.2008.10.034⟩
Vaccine, 2009, 27 (1), pp.28-37. ⟨10.1016/j.vaccine.2008.10.034⟩
Vaccine, Elsevier, 2009, 27 (1), pp.28-37. ⟨10.1016/j.vaccine.2008.10.034⟩
Vaccine, 2009, 27 (1), pp.28-37. ⟨10.1016/j.vaccine.2008.10.034⟩
International audience; The potent IFN-gamma inducing fusion antigen Ag8513-ESAT-6 (85136) is a lead subunit candidate to improve current vaccination against Mycobacterium tuberculosis (Mtb). The recombinant M. bovis BCG strain Myc3504 was constructe
Autor:
Luiz R.R. Castello-Branco, Sunil Gairola, Kevin Markey, Michael J. Corbel, Ivana Knezevic, Sten E. Jensen, Yolanda López-Vidal, Peter Rigsby, Mei M. Ho, Masaaki Seki
Publikováno v:
Vaccine. 26:4754-4757
As part of the World Health Organisation (WHO) initiative to update the current requirements for BCG vaccine a collaborative study was carried out to establish the robustness, reproducibility and the suitability of the modified ATP assay. This assay
Autor:
Jessica R. Lima, Thaíze Pedro, C Cascabulho, P De Luca, Luiz R.R. Castello-Branco, Mariana Siqueira, Carlos G.G. Ponte, Leandro Peres, P. R. Z. Antas, Suelen Marinho
Publikováno v:
Human vaccinesimmunotherapeutics. 11(2)
Tuberculosis (TB) remains the world's leading cause of morbidity and mortality. Although Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the only vaccine currently in use, its efficacy is highly variable. It has been suggested that early antig
Publikováno v:
Memórias do Instituto Oswaldo Cruz., Vol 100, Iss 1, Pp 67-71 (2005)
Memórias do Instituto Oswaldo Cruz, Volume: 100, Issue: 1, Pages: 67-71, Published: FEB 2005
Memórias do Instituto Oswaldo Cruz, Volume: 100, Issue: 1, Pages: 67-71, Published: FEB 2005
In 2003, the Fifth Brazilian Symposium on HIV/AIDS Research was held in Rio de Janeiro, RJ, with 264 participants and comprising lectures delivered by 33 invited speakers, 48 short-presentations, and 137 posters. The main subjects were immunology, ep
Autor:
Francisco Inácio Bastos, F. Bernier, Clara F. T. Yoshida, Monica Derrico, M. I. Linhares-De-Carvalho, Mariza G. Morgado, Michel Alary, Catherine M Lowndes, Luiz R.R. Castello-Branco, Walter M.R. Oelemann, Tatiana Rozental
Publikováno v:
International Journal of STD & AIDS. 11:383-392
A survey was carried out in 2 drug use treatment centres (TCs) in Rio de Janeiro, Brazil, to assess risk behaviours, HIV infection and other sexually transmitted infections/blood-borne infections (STIs/BBIs). Two hundred and twenty-five drug users (1
Publikováno v:
Acta Tropica. 72:31-38
An indirect enzyme linked immunosorbent assay (ELISA) was applied to saliva to detect chronic infection by Trypanosoma cruzi in humans. Saliva samples from 114 Chagas' disease chronically infected individuals, characterized by three serological tests
Autor:
Maria Inêz Linhares-de-Carvalho, M. B. Ortigao-De-Sampaio, Peter Hayes, David Lewis, George E. Griffin, Robin J. Shattock, Luiz R.R. Castello-Branco, Antonio Ponce de Leon
Publikováno v:
AIDS. 12:F145-F150
Constant antigenic stimulation of the large immune cell population contained within gut-associated lymphoid tissue during HIV infection may contribute to patients total viral load. The aim of this investigation was to evaluate the effect of a mucosal